Le Lézard
Classified in: Health
Subject: AVO

Heart & Stroke Applauds Draft Legislation to Recoup Cost of Smoking


Federal government taps Big Tobacco to pay for tobacco control strategy 

OTTAWA, ON, Nov. 21, 2023 /CNW/ - Heart & Stroke lauds the federal government for proposing an amendment of the Tobacco and Vaping Products Act to implement an annual tobacco cost recovery fee in today's Fall Economic Statement. This is a move that would see tobacco companies footing the bill for the federal tobacco control strategy.

The proposed legislation would impose an annual licensing fee on tobacco manufacturers. The total cost of the federal tobacco control strategy is $66 million per year. This figure includes vaping control activities.

"We congratulate the government for this important legislation that will help save lives, and we urge them to move forward with it quickly," said Doug Roth, Heart & Stroke CEO. "Tobacco kills 46,000 people in Canada every year. It's time for tobacco companies to pitch in and mitigate the devastation wrought by their dangerous, addictive products and to turn the tide on smoking in Canada for good."

Although Canada has implemented many effective tobacco control measures over the past decades, almost 12% of Canadians aged 12 and over are current smokers ? a long way from the federal target of less than 5% tobacco use by 2035.

Heart & Stroke also encourages the federal government to finalize comprehensive restrictions on vape flavours (including mint/menthol) to protect youth and to introduce pharmacare legislation in 2023.

About Heart & Stroke

Life. We don't want you to miss it. That's why Heart & Stroke has been leading the fight to beat heart disease and stroke for 70 years. We must generate the next medical breakthroughs, so Canadians don't miss out on precious moments. Together, we are working to prevent disease, save lives and promote recovery through research, health promotion and public policy. Heartandstroke.ca @HeartandStroke

SOURCE Heart and Stroke Foundation


These press releases may also interest you

at 07:00
In recognition of Clinical Trials Day, The Trial for #ClinicalEquality ?a longstanding and widely celebrated initiative from FCB Health New York, an IPG Health company ? continues the fight to increase equity in clinical trials with the next phase of...

at 06:52
According to the latest BCC Research study, the demand for the Global Prenatal Testing Market is expected to grow from $10.9 billion in 2023 and is projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6%...

at 06:32
"According to the latest BCC Research study, the demand for Medical Robotics and Computer-assisted Surgery: The Global Market is expected to grow from $11.5 billion in 2023 and is projected to reach $19.5 billion by the end of 2028, at a compound...

at 06:15
The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., MBBS, as the new leader of the Phase 1 Clinical Trials Multidisciplinary Team and co-leader of the Gastrointestinal (GI) and Neuroendocrine Oncology Multidisciplinary Team...

at 06:07
Seed Health will present new clinical data on its flagship innovation, DS-01® Daily Synbiotic, a 24-strain probiotic and prebiotic, at the upcoming 2024 Digestive Disease Week® (DDW) meeting. The presentations will highlight the results from two...

at 06:05
Arrowhead Pharmaceuticals, Inc. today announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the treatment of inflammatory lung diseases, such as asthma, were presented at the American Thoracic Society (ATS)...



News published on and distributed by: